STOCK TITAN

TransCode Therapeutics Inc - RNAZ STOCK NEWS

Welcome to our dedicated news page for TransCode Therapeutics (Ticker: RNAZ), a resource for investors and traders seeking the latest updates and insights on TransCode Therapeutics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TransCode Therapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TransCode Therapeutics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
offering
-
Rhea-AI Summary
TransCode Therapeutics, Inc. announces pricing of public offering of common stock and warrants
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.05%
Tags
offering
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.05%
Tags
clinical trial
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.28%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.73%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.94%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
31.42%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
31.42%
Tags
none
TransCode Therapeutics Inc

Nasdaq:RNAZ

RNAZ Rankings

RNAZ Stock Data

721.50k
502.26k
1.35%
2.99%
16.54%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States
Boston

About RNAZ

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.